SFS
GSK icon

Sowell Financial Services’s GSK GSK Stock Holding History

Sowell Financial Services’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393K Buy
7,489
+288
+4% +$15.2K 0.01% 756
2026
Q1 		$397K Buy
7,201
+1,199
+20% +$65K 0.01% 722
2025
Q4 		$294K Sell
6,002
-465
-7% -$21.7K 0.01% 843
2025
Q3 		$279K Sell
6,467
-2,108
-25% -$82.3K 0.01% 838
2025
Q2 		$329K Sell
8,575
-1,008
-11% -$38.5K 0.01% 748
2025
Q1 		$371K Sell
9,583
-1,577
-14% -$57.7K 0.02% 676
2024
Q4 		$377K Buy
11,160
+1,029
+10% +$37K 0.02% 439
2024
Q3 		$419K Sell
10,131
-2,978
-23% -$122K 0.02% 461
2024
Q2 		$510K Sell
13,109
-124
-0.9% -$5.22K 0.02% 434
2024
Q1 		$573K Buy
13,233
+472
+4% +$19.5K 0.03% 433
2023
Q4 		$477K Sell
12,761
-298
-2% -$10.7K 0.03% 435
2023
Q3 		$478K Sell
13,059
-23,725
-64% -$842K 0.03% 405
2023
Q2 		$1.32M Buy
36,784
+23,492
+177% +$843K 0.07% 303
2023
Q1 		$473K Sell
13,292
-29,426
-69% -$1.03M 0.04% 441
2022
Q4 		$1.51M Buy
42,718
+28,649
+204% +$954K 0.1% 236
2022
Q3 		$416K Buy
+14,069
New +$533K 0.04% 339
2021
Q3 		– Sell
-11,915
Closed -$601K – 506
2021
Q2 		$601K Sell
11,915
-363
-3% -$17.4K 0.04% 396
2021
Q1 		$582K Buy
12,278
+4,711
+62% +$214K 0.02% 591
2020
Q4 		$348K Buy
7,567
+38
+0.5% +$1.75K 0.01% 637
2020
Q3 		$354K Sell
7,529
-1,548
-17% -$77.6K 0.02% 560
2020
Q2 		$463K Sell
9,077
-3,016
-25% -$155K 0.03% 478
2020
Q1 		$573K Sell
12,093
-561
-4% -$29.9K 0.04% 364
2019
Q4 		$743K Buy
12,654
+2,504
+25% +$139K 0.06% 335
2019
Q3 		$541K Buy
+10,150
New +$522K 0.04% 402
2017
Q1 		– Sell
-1,701
Closed -$86K – 383
2016
Q4 		$86K Buy
+1,701
New +$84K 0.03% 284

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Sowell Financial Services's GSK Position: Q2 2026 in Review

Sowell Financial Services increased its GSK (GSK) stake by 4% in Q2 2026, buying an estimated $15.2K and bringing the position to 7,489 shares worth $393K. The position accounts for 0.01% of the portfolio, ranked #756.

Sowell Financial Services first reported a position in GSK in Q4 2016 and has held it in 25 quarters since. The position peaked at $1.51M in Q4 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Sowell Financial Services held 7,489 shares of GSK worth $393K as of Q2 2026.
  • Sowell Financial Services bought 288 GSK shares in Q2 2026, an estimated $15.2K.
  • GSK made up 0.01% of Sowell Financial Services's portfolio in Q2 2026, its #756 holding.
  • Sowell Financial Services first reported a position in GSK in Q4 2016 and has held it in 25 quarters since.
  • Sowell Financial Services's GSK position peaked at $1.51M in Q4 2022.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.